Israeli Society of Biological Psychiatry Annual Meeting 2026

NeuroKaire at the ISBP Meeting

NeuroKaire was proud to participate in this year’s ISBP Meeting hosted by the Israeli Society of Biological Psychiatry, bringing together leaders in psychiatry, neuroscience, and mental health research.

During the meeting, Orit Goldman, NeuroKaire’s VP of Biology, presented results from our clinical trial in collaboration with Sheba Medical Center. Her presentation highlighted real-world data demonstrating how BrightKaire™ is helping advance personalized depression treatment by using patient-derived neurons and AI-driven insights to better understand antidepressant response.

The presentation offered an important opportunity to share NeuroKaire’s progress with the biological psychiatry community and discuss how precision psychiatry can help reduce the trial-and-error approach that many patients experience when searching for an effective antidepressant.

Highlights:

• Presentation by Orit Goldman, VP of Biology at NeuroKaire
• Clinical trial results from NeuroKaire’s collaboration with Sheba Medical Center
• Real-world data on BrightKaire™ and personalized antidepressant treatment
• Discussion of patient-derived neurons as a tool for advancing precision psychiatry
• Engagement with clinicians, researchers, and leaders in biological psychiatry

NeuroKaire remains committed to advancing science-driven solutions that help clinicians make more informed treatment decisions and improve outcomes for people living with depression.

Missed Us at ISBP?

If you weren’t able to attend, we’d still love to connect! Learn more about how NeuroKaire’s solutions can benefit your practice and improve patient outcomes.

Contact Us or Schedule a Meeting